Jack J. Florio

Jack J. Florio is a Managing Director at Objective Capital Partners in the firm’s healthcare & life science investment banking group. Mr. Florio has 40+ years of global life sciences experience in major pharmaceutical, biotechnology, medical devices and digital health companies.  He has held senior management roles in both small and large companies including CEO, Corporate Development and Business Development.

Mr. Florio began his career at Eli Lilly and Company where he spent almost 30 years in positions of increasing responsibility supporting both domestic and foreign markets in sales, marketing and market research, product and therapeutic area leadership and global pricing. In his last role at Lilly, he successfully created the Late Life Cycle Products Team, a group responsible for the planning and divestiture of products as they moved into the latter part of their life cycle. Over the course of his career, he covered multiple therapeutic areas including neuroscience, anti-infectives, liver disease, pain and inflammation, gastrointestinal disorders, metabolic diseases and oncology.

In the past 14 years, in addition to opening the West Coast office for Brinson Patrick Securities as an investment banker, Mr. Florio held executive roles in different companies in areas of corporate development, business development and as Chief Executive Officer. He currently serves in formal advisory roles on several companies in the pharmaceutical, medical device and digital health spaces.

Concurrent with his role at Objective Capital, Mr. Florio is a Partner at Deallus Consulting, a UK based Global life sciences consultancy.  He is also on the BIOCOM Board of Directors and serves a role on BIOCOM’s Capital Development Committee.  He is an active investor in life science companies with Tech Coast Angels since 2001 where he served on the Board of Directors for 8 years. He is currently on the BIO 2017 International Planning Committee and the InvestSW Venture Madness Review Committee.

Mr. Florio holds both a Masters of Business Administration Degree with a marketing concentration as well as an APC in Management from New York University. Additionally, he holds a Bachelor of Science Degree in Pharmacy from Columbia University, College of Pharmaceutical Sciences.

Mr. Florio holds FINRA Series 7 and 63 licenses.